Blog

Even if you save nicely for your senior years, you'll probably count on Social Security a lot for retirement expenses, so it pays to get as much money as you can out of it. Here are a few strategies

Extending their southward-bound journey from January, shares of Yamana Gold (NYSE: AUY) fell 13.9% last month, according to data from S&P Global Market Intelligence. The gold stock has, however

The stock of Ulta Beauty (NASDAQ: ULTA) has spent all of the past year trailing the broader market. The pandemic's impact has been a lift for many retailers, but demand has dropped for Ulta's skin

Digital ad-buying expert The Trade Desk (NASDAQ: TTD) is a fantastic deal right now. The stock's high-octane growth in 2020 turned into a rout in the last couple of months, for all the wrong

After sinking more than 6% through 2020, shares of Kirkland Lake Gold (NYSE: KL) have followed the same downward trajectory in the beginning of 2021. Falling 7% in January, Kirkland Lake's stock

Most e-commerce companies got a massive boost in 2020. Etsy, Shopify, and Wayfair saw their share prices jump 100% or more in the past year due to an increased demand for online shopping. One

Shares of Fiverr (NYSE: FVRR) jumped 30.7% in February, according to data provided by S&P Global Market Intelligence.

The company, which hosts a platform for freelance services, has seen its stock

Shares of Canopy Growth (NASDAQ: CGC) fell 18.1% in February, according to data provided by S&P Global Market Intelligence. The Canadian pot stock fell despite a relatively good earnings report and

Shares of Norwegian Cruise (NYSE: NCLH) surged 30.5% in February, according to data provided by S&P Global Market Intelligence.

The cruise company's stock is trading at a one-year high but is still

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) recently started a clinical trial testing their coronavirus vaccine in pregnant women. While this subset of the market would seem to be a minor

Shares of Bank of America (NYSE: BAC), US Bancorp (NYSE: USB), and Synovus Financial (NYSE: SNV) rose 17.1%, 16.7%, and 13.7%, respectively, in February, according to data provided by S&P Global

Novavax (NASDAQ: NVAX) reached an agreement to sell 1.1 million doses of its coronavirus vaccine to COVAX, an organization led by the Coalition of Epidemic Preparedness Innovations, Gavi, and the

While Intercontinental Exchange (NYSE: ICE) is most famous for owning the New York Stock Exchange, it has also been investing heavily in the mortgage space. And on the company's fourth-quarter

Spending $5 for a cup of coffee or eating cheeseburgers and fries -- I don't know which is more American.

Starbucks (NASDAQ: SBUX) paved the way for the masses to experience a premium coffeehouse

Dividend stocks can make excellent long-term investments. They allow investors to earn passive income while also benefiting from the upside of a rising stock price. That one-two punch has

Saving for retirement throughout your career may have left you with investments in several different types of accounts. 

By the time you retire, you could have a 401(k) from work, an IRA for

Can a diagnostics company that makes most of its money from coronavirus tests keep growing in a post-pandemic environment? Fulgent Genetics (NASDAQ: FLGT) shares are still far below their peak in

If you invested in Amazon stock 10 years ago and held on to your shares, the value of your position would have grown roughly 1,660%. An investment in Netflix stock would have yielded a 1,720% return

Canadian weed giant Tilray (NASDAQ: TLRY) was on a tear for much of 2020. Despite the stock market woes of the past week, its shares have gone up nearly 60% over the past 12 months, making it one of

Target (NYSE: TGT) recently announced results from its final quarter of fiscal 2020 in line with the update management provided a few months ago. Revenue increased 21% year over year to $28.0

The coronavirus vaccine space is constantly changing. It began last year as high-risk. This year, companies have brought products to market. Risk has declined for those players and others that have

The past year has been a wild one -- in real life and in the stock market. But for shareholders of Axon Enterprise (NASDAQ: AXON), the roller-coaster ride of the past couple of months has been

Ocugen (NASDAQ: OCGN) officially joined the coronavirus vaccine race last month when it partnered with Indian company Bharat Biotech -- which already had a vaccine candidate in phase 3 studies in

Johnson & Johnson (NYSE: JNJ) is selling its vaccine without taking a profit during the pandemic. In this Motley Fool Live video recorded on Feb. 26, 2021, healthcare and cannabis bureau chief

Ocugen (NASDAQ: OCGN) is a latecomer to the coronavirus vaccine race. It recently gained rights to co-commercialize Bharat Biotech's vaccine candidate in the U.S. In this Motley Fool Live video